Table 1.
Variable | Number | Percent |
---|---|---|
Age, range (median) | 15–87 (52) | |
≤ 50 year | 97 | 44.3 |
> 50 year | 122 | 55.7 |
Gender | ||
Male | 161 | 73.5 |
Female | 58 | 26.5 |
Educational level | ||
≤ 12 year | 165 | 75.3 |
> 12 year | 54 | 24.7 |
Marital status | ||
With spouse | 160 | 73.1 |
Without spouse | 59 | 26.9 |
Smoking history | ||
Yes | 92 | 42.0 |
No | 127 | 58.0 |
Charlson comorbidity index | ||
0 | 125 | 57.1 |
≥ 1 | 94 | 42.9 |
Body mass index | ||
< 23 | 62 | 28.8 |
≥ 23 | 157 | 71.2 |
WHO histology | ||
Type I | 3 | 1.4 |
Type IIA | 98 | 44.7 |
Type IIB | 118 | 53.9 |
Clinical stagea | ||
I | 27 | 12.3 |
II | 45 | 20.6 |
III | 67 | 30.6 |
IVA-B | 80 | 36.5 |
T classificationa | ||
T1 | 98 | 44.7 |
T2 | 35 | 16.0 |
T3 | 48 | 21.9 |
T4 | 38 | 17.4 |
N classificationa | ||
N0 | 37 | 16.9 |
N1 | 72 | 32.9 |
N2 | 64 | 29.2 |
N3 | 46 | 21.0 |
Chemotherapy | ||
Concurrent chemotherapy | 192 | 87.7 |
Adjuvant chemotherapy | 144 | 65.8 |
WHO World Health Organization
aAccording to the AJCC 7th staging system